Anavex Life Sciences Corp.
corporate_fare Company Profile
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 43 items for AVXL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-28, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for AVXL spans 8-K, DFAN14A, DEFA14A, 10-Q.
Recent high-impact activity:
- Anavex Board Survives Proxy Contest; All Six Company Nominees Elected, Triggering Change-in-Control Vesting
- PVG Hosts Investor Town Hall, Details Board Overhaul Plan and Funding Gap
- PVG Unveils 100-Day Turnaround Plan for Anavex, Citing Glass Lewis Backing
- Glass Lewis Backs PVG's Proxy Fight, Recommends Against Anavex Chair and One Other Incumbent
- Anavex Discloses FDA Pediatric Meeting and Two New Board Nominees in Proxy Fight
Financial Snapshot
Short Interest & Short Volume
13.56 days to coverFINRA reported short interest of 13,566,524 shares in AVXL as of the September 30, 2026 settlement, a 5.3% decrease from the prior period — about 13.6 days to cover at its recent average daily volume. On October 9, 2026, 65.2% of AVXL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.